Literature DB >> 12738633

Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model.

Ulla Airaksinen1, Tuula Penttilä, Eva Wahlström, Jenni M Vuola, Mirja Puolakkainen, Matti Sarvas.   

Abstract

Due to intracellular growth requirements, large-scale cultures of chlamydiae and purification of its proteins are difficult and laborious. To overcome these problems we produced chlamydial proteins in a heterologous host, Bacillus subtilis, a gram-positive nonpathogenic bacterium. The genes of Chlamydia pneumoniae major outer membrane protein (MOMP), the cysteine-rich outer membrane protein (Omp2), and the heat shock protein (Hsp60) were amplified by PCR, and the PCR products were cloned into expression vectors containing a promoter, a ribosome binding site, and a truncated signal sequence of the alpha-amylase gene from Bacillus amyloliquefaciens. C. pneumoniae genes were readily expressed in B. subtilis under the control of the alpha-amylase promoter. The recombinant proteins MOMP and Hsp60 were purified from the bacterial lysate with the aid of the carboxy-terminal histidine hexamer tag by affinity chromatography. The Omp2 was separated as an insoluble fraction after 8 M urea treatment. The purified proteins were successfully used as immunogens and as antigens in serological assays and in a lymphoproliferation test. The Omp2 and Hsp60 antigens were readily recognized by the antibodies appearing after pulmonary infection following intranasal inoculation of C. pneumoniae in mice. Also, splenocytes collected from mice immunized with MOMP or Hsp60 proteins proliferated in response to in vitro stimulation with the corresponding proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738633      PMCID: PMC154951          DOI: 10.1128/cdli.10.3.367-375.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  44 in total

1.  REQUIREMENTS FOR TRANSFORMATION IN BACILLUS SUBTILIS.

Authors:  C Anagnostopoulos; J Spizizen
Journal:  J Bacteriol       Date:  1961-05       Impact factor: 3.490

2.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

3.  Analysis of the humoral immune response to Chlamydia outer membrane protein 2.

Authors:  P Mygind; G Christiansen; K Persson; S Birkelund
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

4.  Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation.

Authors:  A Essig; U Simnacher; M Susa; R Marre
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

5.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma.

Authors:  D L Hahn; R W Dodge; R Golubjatnikov
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Identification of Chlamydia pneumoniae-specific protein antigens in immunoblots.

Authors:  H M Freidank; A S Herr; E Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

8.  Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans.

Authors:  Y Iijima; N Miyashita; T Kishimoto; Y Kanamoto; R Soejima; A Matsumoto
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases.

Authors:  X C Wu; W Lee; L Tran; S L Wong
Journal:  J Bacteriol       Date:  1991-08       Impact factor: 3.490

10.  A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis.

Authors:  Z P Yang; C C Kuo; J T Grayston
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more
  4 in total

1.  Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts.

Authors:  Laura Mannonen; Eveliina Markkula; Mirja Puolakkainen
Journal:  Med Microbiol Immunol       Date:  2011-01-30       Impact factor: 3.402

2.  Flotillin-1 (Reggie-2) contributes to Chlamydia pneumoniae growth and is associated with bacterial inclusion.

Authors:  Juha T Korhonen; Mirja Puolakkainen; Reetta Häivälä; Tuula Penttilä; Anu Haveri; Eveliina Markkula; Riitta Lahesmaa
Journal:  Infect Immun       Date:  2012-01-03       Impact factor: 3.441

3.  Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Leena Erkkilä; Taina Korhonen; Terttu Tiirola; Aini Bloigu; Pekka Saikku; Maija Leinonen
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Development and characterization of a subtilin-regulated expression system in Bacillus subtilis: strict control of gene expression by addition of subtilin.

Authors:  Roger S Bongers; Jan-Willem Veening; Maarten Van Wieringen; Oscar P Kuipers; Michiel Kleerebezem
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.